Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 75.0M | 75.5M | 59.8M | 77.9M |
| Cost of revenue | 13.7M | 15.7M | 19K | 16.6M |
| Gross profit | 61.2M | 59.8M | 59.8M | 61.3M |
| Operating expense | ||||
| Research & development | 182.8M | 97.2M | 93.0M | 73.6M |
| Selling general and admin | 43.8M | 3.7M | 46.6M | 15.8M |
| Other operating expenses | -6.6M | 8.4M | -21.2M | 5.8M |
| Operating income | -158.7M | -62.7M | -54.3M | -38.2M |
| Non operating interest income | ||||
| Income | 12.6M | 17.2M | 23.1M | 23.7M |
| Expense | — | 97K | 695K | -135K |
| Other income expense | -9.4M | 64.0M | -17.7M | 18.8M |
| Pretax income | -156.4M | 19.0M | -49.1M | 4.1M |
| Tax provision | -1.8M | -93K | -571K | -571K |
| Net income | -153.4M | 25.3M | -50.4M | 9.0M |
| Basic EPS | -0.1 | — | — | — |
| Diluted EPS | -0.1 | — | — | — |
| Basic average shares | 1.3B | — | — | — |
| Diluted average shares | 1.3B | — | — | — |
| EBITDA | -149.3M | 59.4M | -135.1M | 41.4M |
| Net income from continuing op. | -153.4M | 25.3M | -50.4M | 9.0M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |